News and Announcements
COMMENTARY
Fight for men’s health: Call of bladder cancer and prostate cancer screening
Chong Li1*
Show Less
1
Core Facility for Protein Research, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101,
China
CP 2019, 1(2), 1–2;
Accepted: 3 June 2019 | Published: 21 June 2019
© 2019 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
References
Chen W, Zheng R, Baade PD, et al., 2016, Cancer Statistics in China, 2015. CA Cancer J Clin, 66(2):115-32.
Han SJ, Zhang SW, Chen WQ, et al., 2013, Analysis of the Status and Trends of Bladder Cancer Incidence in China (in Chinese). PLoS One, 11(1):89-95.
China Anti-Cancer Association, Genitourinary Cancer Committee, Prostate Cancer Working Group, 2017, Consensus of Prostate Cancer Screening (in Chinese). Chin J Surg, 55(5):340-2.
Han JF, Wang WH, Jia Q, (2009) Values of PSA, DRE and TRS in Prostate Cancer Screening (in Chinese). J Chin Prac Diag, 23(5):476-7.